The Democratic Republic of the Congo's (DRC) 17th Ebola outbreak, caused by the Bundibugyo virus and declared a Public Health Emergency of International Concern (PHEIC) on 17 May 2026, has been spreading across the provinces of Ituri, North Kivu, and South Kivu, with confirmed cross-border transmission into the Ugandan capital, Kampala.
Critical containment gaps, including insecurity and conflict, a contact follow-up rate well below the target level, infections among healthcare workers, deficiencies in infection prevention and control (IPC), and a funding shortfall, are sustaining transmission. The absence of an approved vaccine for this species of ebolavirus limits the range of available countermeasures.
On 2 June 2026, WHO reported that the number of suspected cases in the DRC had decreased compared to previous reports after many were ruled out through investigation and testing. This decline reflects case reclassification rather than necessarily reduced transmission.
D.R. Congo: data as of 04 June 2026 (for updates see WHO dashboard and ECDC):
Uganda: data as of 04 June 2026 (for updates see WHO dashboard and ECDC):
Outside Africa:
Entry and exit screenings and control measures:
Authorities are concerned about the risk of further spread due to population high mobility, insecurity, and the proximity of affected areas to Uganda and South Sudan through a porous border.
Distribution of suspected and confirmed Bundibugyo virus disease cases in the Democratic Republic of the Congo and Uganda, as of 6 June 2026:
WHO assesses the risk of the epidemic as very high at the national level, high at regional levels, and low at the global level (including Switzerland and the EU/EEW). For details, see LINK.
ECDC assesses the risk for EU/EEA travellers in affected areas as low if precautions (see under “consequences for travelers”) are followed but emphasizes uncertainties and rapid evolution.
Due to the very recent declaration of the outbreak and the uncertainties related to the
epidemiological information, it is probable that the outbreak is much larger than what is currently
being reported – not only in regards to the number of affected cases, but also in its geographical extent.
The situation is evolving rapidly! Always stay informed before, during, and after travel! As of 11 June 2026:
The following precautions are recommended for all travel to the DRC and Uganda as well as in neighboring countries:
General preventive measures:
Of note: there is currently no licensed vaccine or specific treatment against Ebola diseased caused by Bundibugyo virus. For humanitarian missions, consultation with a travel medicine specialist is recommended.
While in the affected areas in DRC and in Uganda and for 21 days after leaving:
! In case of symptoms headache, body aches, muscle pain, fatigue, loss of appetite, vomiting or diarrhea during your stay in and for 21 days after leaving north-eastern D.R. Congo (province of Ituri, North Kivu, South Kivu) and /or Uganda, especially the affected areas:
Recommendations of the Swiss Expert Committee for Travel Medicine (as of 11 June 2026, subject to change according to the evolving situation):
A suspected case is:
Such cases should be isolated, tested, and reported to the Cantonal Physician and the Swiss Federal Office of Public Health within 2 hours.
*High-risk exposure includes:
Between January and mid-April 2026, Zimbabwe reported 65’399 malaria cases and 174 deaths, nearly double the number of cases reported during the same period in 2025 (around 36'000) and almost four times the 2024 total (around 17’000). The outbreak has affected multiple districts across Manicaland, Mashonaland Central, Mashonaland East, and Mashonaland West, including areas previously nearing elimination.
Similar increases are being observed across other countries in Southern Africa Region. The surge has been linked to heavy rainfall during the 2025–2026 season, which created favorable mosquito-breeding.
Meteorological forecasts predict increased rainfall across southern African countries in the upcoming months. Given the already high malaria case numbers from January to May 2026 in Namibia, Botswana, and Zimbabwe, it is possible that these countries will face heightened malaria risk from June to August, even in areas where risk is typically moderate during these months.
Optimal mosquito protection 24/7 (at dusk and at night against malaria, during the day against other arboviruses).
Malaria chemoprophylaxis is recommended, including during the usually moderate transmission period from June to August in seasonal risk areas, given the recent increase in malaria cases and the forecasted increased precipitations in the upcoming months and favorable conditions for mosquito breeding.
A man from Ramanattukara, Kozhikode, Kerala, was tested positive for Nipah on 11 June 2026. The patient is in critical condition. The infection is suspected to be linked to bat exposure while cleaning a storage facility. A total of 77 contacts have been identified.
Nipah virus outbreaks have been reported previously in Kerala and other states of India.
Follow official and media reports. Follow local instructions.
Avoid contact with sick persons and animals (bats) and avoid contact with their excreta. Avoid consumption of raw fruit juices and unwashed, especially bitten, tree fruits or vegetables. Consult a doctor if symptoms appear. There is neither a vaccination for humans nor a specific treatment.
The Swiss Federal Office of Public Health has launched an awareness initiative at airports to promote mosquito bite prevention during travel and for up to 14 days after return. The initiative aims to reduce the risk of importing mosquito-borne viruses such as chikungunya, dengue, and Zika into Switzerland.
On 15 May 2026, the DRC declared a Bundibugyo Ebola outbreak, while Uganda reported two imported cases. WHO declared a Public Health Emergency of International Concern (PHEIC) on 16 May, see EpiNews 21.5 2026.
As of 26 May 2026:
D.R. Congo:
WHO expects those numbers to keep increasing, given the amount of time the virus was circulating before the outbreak was detected.
Uganda:
Further cases:
Exit screening and control measures:
Authorities are concerned about the risk of further spread due to population high mobility, insecurity, and the proximity of affected areas to Uganda and South Sudan through a porous border.
Distribution of suspected and confirmed Bundibugyo virus disease cases in the Democratic Republic of the Congo and Uganda, as of 24 May 2026:
WHO assesses the risk of the epidemic as very high at the national level, high at regional levels, and low at the global level (including Switzerland and the EU/EEW). For details, see LINK.
ECDC: Due to the very recent declaration of the outbreak and the uncertainties related to the
epidemiological information, it is probable that the outbreak is much larger than what is currently
being reported – not only in regard to the number of affected cases, but also to its geographical
extent.
ECDC assesses the risk for EU/EEA travellers in affected areas as low if precautions (see below) are followed but emphasizes uncertainties and rapid evolution.
ECDC considers that screening of returning travellers from affected areas (DRC, Uganda) would not be an effective measure to prevent introduction to Europe. This consideration is based on the lessons learned and results of the large EVD outbreak in West Africa between 2013 and 2016, where tens of thousands of cases were reported, transmission was ongoing in large urban centres, and hundreds of EU/EEA humanitarian and military personnel were deployed to the affected areas. Screening incoming travellers is time- and resource-consuming and will not effectively identify infected cases.
Priority should instead be given to providing travellers with clear information on symptoms, routes of transmission, and what to do if symptoms develop after arrival in the EU/EEA. For details, see ECDC Threat Assessment, 21 May 2026.
The situation is evolving rapidly! Always stay informed before, during, and after travel! As of 11 June 2026:
The following precautions are recommended for all travel to the DRC and Uganda as well as in neighboring countries:
General preventive measures:
Of note: there is currently no licensed vaccine or specific treatment against Ebola diseased caused by Bundibugyo virus. For humanitarian missions, consultation with a travel medicine specialist is recommended.
While in the affected areas in DRC and in Uganda and for 21 days after leaving:
! In case of symptoms such as fever or feeling feverish, and any of the following symptoms: headache, body aches, muscle pain, fatigue, loss of appetite, vomiting or diarrhea during your stay in and for 21 days after leaving north-eastern D.R. Congo (province of Ituri, North Kivu, South Kivu) and /or Uganda, especially the affected areas:
Swiss ECTM recommendations (as of 11 June 2026, subject to change according to the evolving situation):
A suspected case is:
Such cases should be isolated, tested, and reported to the Cantonal Physician and the Swiss Federal Office of Public Health within 2 hours.
*High-risk exposure includes:
As of 29 May 2026, 197 malaria cases have been reported in Mayotte:
The predominant species is Plasmodium falciparum. This is a marked increase compared to April 2026. The increase in local transmission represents a setback for Mayotte's malaria elimination efforts.
Optimal mosquito protection 24/7 (at dusk and at night against malaria, during the day against dengue, chikungunya and other arboviruses).
In case of fever, malaria should always be ruled out by blood test.
0